tiprankstipranks
AnaptysBio Inc (GB:0HFQ)
LSE:0HFQ

AnaptysBio (0HFQ) Financial Statements

0 Followers

AnaptysBio Financial Overview

AnaptysBio's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; AnaptysBio is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-1.51. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 9.01M$ 3.32M$ 3.46M$ 1.37M$ 6.81M
Gross Profit$ 9.01M$ 3.32M$ 3.46M$ 1.37M$ 6.81M
EBIT$ -42.22M$ -37.31M$ -39.84M$ -44.26M$ -25.98M
EBITDA$ -34.24M$ -39.71M$ -41.44M$ -45.85M$ -25.37M
Net Income Common Stockholders$ -42.21M$ -37.31M$ -39.84M$ -44.26M$ -26.37M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 390.90M$ 413.05M$ 429.49M$ 431.15M$ 441.24M
Total Assets$ 452.39M$ 487.33M$ 517.10M$ 549.81M$ 610.38M
Total Debt$ 17.81M$ 18.23M$ 18.65M$ 19.06M$ 19.45M
Net Debt$ -373.09M$ -394.81M$ -410.83M$ -412.09M$ -421.79M
Total Liabilities$ 364.29M$ 366.94M$ 368.65M$ 360.70M$ 348.28M
Stockholders Equity$ 88.10M$ 120.38M$ 148.45M$ 191.09M$ 262.10M
Cash Flow-
Free Cash Flow$ -34.63M$ -36.64M$ -25.60M$ -24.74M$ -10.86M
Operating Cash Flow$ -34.35M$ -36.47M$ -25.41M$ -24.57M$ -10.69M
Investing Cash Flow$ 49.18M$ 30.64M$ -20.45M$ 85.40M$ 21.50M
Financing Cash Flow$ -5.16M$ -3.07M$ -13.49M$ -37.57M$ 1.95M
Currency in USD

AnaptysBio Earnings and Revenue History

AnaptysBio Debt to Assets

AnaptysBio Cash Flow

AnaptysBio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis